Global market research and consulting company Markets and Markets reports that the global flow cytometry market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% during 2013-2018, to reach $3.7 billion by 2018.
Flow cytometry applications in laboratory medicine have grown significantly in the past decade. These techniques are important tools in scientific research and diagnosis and are used routinely in many labs to detect the presence of specific surface and intracellular markers, and measure metabolic activity, DNA content, HIV infection and auto antibodies. The advances in flow technology have also improved the accuracy of testing and turnaround times and the objectivity of the results.
Factors driving the growth of the global cytometry market according to the Markets and Markets report include technological advancements in the flow cytometry instruments, increased use of flow cytometry techniques in research activities, growing clinical trials, fostering prevalence of HIV and cancer, availability of new reagents for specific applications such as diagnostics, drug discovery, and the development of user friendly and intuitive software.
The report looks at the global market on the basis of the type of technology, products & services, applications and type of end users. On the basis of the type of technology, the flow cytometry market is segmented into cell-based, bead-based, and others. The cell-based flow cytometry segment accounted for the largest share of the global market in 2013, though bead based flow cytometry is expected to grow at a higher rate due to decreased system cost, better statistical performance, and enhanced hybridization kinetics.
The products and services market is segmented into instruments, reagents and consumables, software, services, and accessories. It is categorized into three on the basis of the type of applications: research fields, clinical applications, and industrial applications. End users include commercial organizations, hospitals, academic institutions, medical schools, and clinical testing labs.
The study also points out the factors that are restricting the growth of this market: high cost of instruments, reluctance among researchers to use flow cytometers, dearth of training, and lack of awareness among probable users.
Geographically, North America accounted for the largest share of the global market in 2013 and this growth is credited to a number of factors such as presence of flow cytometry associations in this region, increasing use of these techniques in cancer research, rise in investment initiatives by the government, and high quality infrastructure for clinical and laboratory research. Emerging markets including China and India are becoming attractive for the companies engaged in the development and marketing of the products.
As of 2013, Becton, Dickinson and Company (U.S.) and Beckman Coulter, Inc. (U.S.) account for 50% of the flow cytometry market. Other key players include eBioscience, Inc. (U.S.), EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.). Leading lab equipment suppliers supply various models of flow cytometers from established manufacturers.